Antibodies cocktail treatment showed successful results, says BMC

The Brihanmumbai Municipal Corporation (BMC) on Monday, July 12, stated that more than 200 coronavirus patients have been cured during a preliminary experiment of a cocktail of two antibody drugs, Casirvimab and Imdevimab.

According to BMC, an experiment with a combination of two antibody drugs was performed on patients at the Seven Hills Hospital in Andheri. They showed a remarkable recovery following treatment with the monoclonal antibodies.

An official mentioned that the number of patients in need of oxygen after this cocktail medication is only 0.5 per cent and the mortality rate is reduced by a staggering 70 per cent.

Moreover, the duration of treatment in the hospital has been reduced from 13 to 14 days and now it is reduced to five to six days.

A combination of two antibody drugs, Casirivimab and Imdevravimab, has been used in the United States since November 2020 to treat COVID-19 patients.

The monoclonal antibody cocktails can be given to patients above 12 years of age who weigh at least 40 kg. No side effects have been reported in any of the patients, it said.

To date, 212 COVID-19 patients have been given this mixed drug through saline. Out of these, conclusions were reached at the end of 199 patients.

A detailed study is being done by the administration. These 199 patients included 101 patients in the age group of 18 to 45 years, 45 patients in the age group of 45 to 59 years and 53 patients in the age group of 60 years. Out of a total of 199, 74 have at least one co-morbidity.

The municipal corporation said all these 199 patients were in the mild to moderate infection group. These mixed medications are given to mild to moderate patients who are affected by viruses and do not need oxygen supply but are at risk of further deterioration.

Importantly, it is also possible to treat people with diabetes, kidney disease, heart disease, asthma and other acute respiratory diseases like it, high blood pressure, sickle cell, cerebral palsy etc.

Also Read: Fortis Hospital administers the first 'antibody cocktail' to a 72-year-old COVID-19 patient